VIVUS, Inc. News Headlines

Get VVUS Alerts
*Delayed - data as of Sep. 1, 2015 12:13 ET  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By

Why Vivus Is Undervalued At Anything Under $10 Per Share
4/30/2015 8:38:00 AM - Seeking Alpha

Orexigen: Contrave Sales Pop, Equity Response Muted
4/24/2015 7:39:00 PM - Seeking Alpha

Orexigen Investors Can Get Litigation Insight From Vivus
4/24/2015 8:29:00 AM - Seeking Alpha

Orexigen Faces Generic Challenge For Anti-Obesity Drug
4/22/2015 12:24:00 PM - Seeking Alpha

Vivus Sales Remain Flat - Stock Trend Not Good
4/13/2015 1:19:00 PM - Seeking Alpha

Novo Nordisk Quietly Becoming Big Player In Obesity Space
4/9/2015 11:45:00 AM - Seeking Alpha

Novo Nordisk Entry Is Bullish For The Anti-Obesity Space
4/2/2015 9:20:00 PM - Seeking Alpha

Vivus Offers Operational Update - Is Trouble Brewing?
3/31/2015 10:02:00 AM - Seeking Alpha

Orexigen Will Make The Obesity Space A Two-Product Race
3/30/2015 2:21:00 PM - Seeking Alpha

Has Orexigen Delivered A Death Knell To Vivus?
3/27/2015 10:37:00 AM - Seeking Alpha